Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Niroomand

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 1, 1996
Opioid receptor agonists activate pertussis toxin-sensitive G proteins and inhibit adenylyl cyclase in canine cardiac sarcolemmaF Niroomand, R A Mura, L Piacentini, et al.
Biochimica Et Biophysica Acta|June 13, 1996
Stable GDP analog-induced inactivation of G(i) proteins promotes cardiac adenylyl cyclase inhibition by guanosine 5'-(beta gamma-imino)triphosphate and muscarinic acetylcholine receptorL Piacentini, R Mura, K H Jakobs, et al.
European Journal of Pharmacology|March 29, 1988
Is arginine a physiological precursor of endothelium-derived nitric oxide?H H Schmidt, M M Klein, F Niroomand, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|September 1, 1992
Localization of Mycobacterium avium-intracellulare within a skin lesion of bacillary angiomatosis in a patient with AIDSP M Sagerman, D A Relman, F Niroomand, et al.
Heart (British Cardiac Society)|February 1, 1997
Adaptation of myocardial blood flow to increased metabolic demand is not dependent on endothelial vasodilators in the rat heartC P Tiefenbacher, H Tillmanns, F Niroomand, et al.
Journal of Food Protection|August 26, 1998
Fate of bacterial pathogens and indicator organisms in liquid sweetenersF Niroomand, W H Sperber, V J Lewandowski, et al.
Journal of Molecular and Cellular Cardiology|May 1, 1997
Receptor-independent activation of cardiac adenylyl cyclase by GDP and membrane-associated nucleoside diphosphate kinase. A new cardiotonic mechanism?F Niroomand, R Mura, K H Jakobs, et al.
American Journal of Respiratory and Critical Care Medicine|September 1, 1994
Nifedipine does not prevent acute mountain sicknessE Hohenhaus, F Niroomand, S Goerre, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 8, 2003
Reduction of myocardial infarct size by fluvastatinC P Tiefenbacher, J Kapitza, V Dietz, et al.
Heart (British Cardiac Society)|May 16, 2003
Comparative follow up of patients with implanted cardioverter-defibrillators after induction of sustained monomorphic ventricular tachycardias or ventricular fibrillation by programmed stimulationM Meyborg, R Mura, C Tiefenbacher, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 1, 1996
Opioid receptor agonists activate pertussis toxin-sensitive G proteins and inhibit adenylyl cyclase in canine cardiac sarcolemmaF Niroomand, R A Mura, L Piacentini, et al.
Biochimica Et Biophysica Acta|June 13, 1996
Stable GDP analog-induced inactivation of G(i) proteins promotes cardiac adenylyl cyclase inhibition by guanosine 5'-(beta gamma-imino)triphosphate and muscarinic acetylcholine receptorL Piacentini, R Mura, K H Jakobs, et al.
European Journal of Pharmacology|March 29, 1988
Is arginine a physiological precursor of endothelium-derived nitric oxide?H H Schmidt, M M Klein, F Niroomand, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|September 1, 1992
Localization of Mycobacterium avium-intracellulare within a skin lesion of bacillary angiomatosis in a patient with AIDSP M Sagerman, D A Relman, F Niroomand, et al.
Heart (British Cardiac Society)|February 1, 1997
Adaptation of myocardial blood flow to increased metabolic demand is not dependent on endothelial vasodilators in the rat heartC P Tiefenbacher, H Tillmanns, F Niroomand, et al.
Journal of Food Protection|August 26, 1998
Fate of bacterial pathogens and indicator organisms in liquid sweetenersF Niroomand, W H Sperber, V J Lewandowski, et al.
Journal of Molecular and Cellular Cardiology|May 1, 1997
Receptor-independent activation of cardiac adenylyl cyclase by GDP and membrane-associated nucleoside diphosphate kinase. A new cardiotonic mechanism?F Niroomand, R Mura, K H Jakobs, et al.
American Journal of Respiratory and Critical Care Medicine|September 1, 1994
Nifedipine does not prevent acute mountain sicknessE Hohenhaus, F Niroomand, S Goerre, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 8, 2003
Reduction of myocardial infarct size by fluvastatinC P Tiefenbacher, J Kapitza, V Dietz, et al.
Heart (British Cardiac Society)|May 16, 2003
Comparative follow up of patients with implanted cardioverter-defibrillators after induction of sustained monomorphic ventricular tachycardias or ventricular fibrillation by programmed stimulationM Meyborg, R Mura, C Tiefenbacher, et al.
Pageof 4